Study of Kidney Tumors in Younger Patients

NCT00898365 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8000

Last updated 2026-05-18

No results posted yet for this study

Summary

This research trial studies kidney tumors in younger patients. Collecting and storing samples of tumor tissue, blood, and urine from patients with cancer to study in the laboratory may help doctors learn more about changes that occur in deoxyribonucleic acid (DNA) and identify biomarkers related to cancer.

Conditions

  • Adult Cystic Nephroma
  • Anaplastic Kidney Wilms Tumor
  • Angiolipoma
  • Cellular Congenital Mesoblastic Nephroma
  • Classic Congenital Mesoblastic Nephroma
  • Clear Cell Sarcoma of the Kidney
  • Congenital Mesoblastic Nephroma
  • Cystic Partially Differentiated Kidney Nephroblastoma
  • Diffuse Hyperplastic Perilobar Nephroblastomatosis
  • Extrarenal Rhabdoid Tumor
  • Kidney Medullary Carcinoma
  • Kidney Neoplasm
  • Kidney Oncocytoma
  • Kidney Wilms Tumor
  • Metanephric Adenofibroma
  • Metanephric Adenoma
  • Metanephric Stromal Tumor
  • Metanephric Tumor
  • Mixed Congenital Mesoblastic Nephroma
  • Ossifying Renal Tumor of Infancy
  • Papillary Renal Cell Carcinoma
  • Renal Cell Carcinoma
  • Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions
  • Rhabdoid Tumor of the Kidney
  • Wilms Tumor

Interventions

OTHER

Cytology Specimen Collection Procedure

Correlative studies

OTHER

Laboratory Biomarker Analysis

Correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Elizabeth A Mullen · Children's Oncology Group

Eligibility

Max Age
29 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-27
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • United States
  • Australia
  • Canada
  • Israel
  • New Zealand
  • Puerto Rico
  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00898365 on ClinicalTrials.gov